News
CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on ...
The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...
Fewer Kentucky kindergarten students have received the vaccines required to attend school, and data from the state's School ...
Robert F. Kennedy Jr., the HHS Secretary of the US, despite a long history of the contray, now often pretends to be not against vaccinations. Yet, his recent actions depict an entirely different ...
The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to ...
On Wednesday, after the news that the HHS was terminating crucial vaccine development projects worth $500 million, Cassidy called the decision "unfortunate" in a post on the X social network. That’s a ...
The pharma giant will also receive a 1% royalty on future U.S. sales of influenza, Covid-19 and other related combination ...
Whether it’s county, state, or federal, trails in Pima County do not close, unlike in the Phoenix area. The Marana Town ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer ...
The chairman of the Senate Health, Education, Labor and Pensions Committee denounced a decision by the federal government to ...
U.S. Health Secretary Robert F. Kennedy Jr. incorrectly argued mRNA vaccines are ineffective to justify the Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results